Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response. (2021)
Attributed to:
Novel strategies to improve the effectiveness of radiation and targeted therapies in lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-20-0177
PubMed Identifier: 33558336
Publication URI: http://europepmc.org/abstract/MED/33558336
Type: Journal Article/Review
Volume: 81
Parent Publication: Cancer research
Issue: 7
ISSN: 0008-5472